RxDoctor Payments Data

Nader Abdelsayed

Obstetrics & Gynecology · North Las Vegas, NVNPI 1972554756

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.2% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 25.5% of the total.

$3,540in general payments, 2019–2025

Across 136 payments — averaging $26.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$901
  • Daiichi Sankyo Inc.$676
  • Astellas Pharma US Inc$440
  • Hologic Sales And Service, LLC$197
  • Applied Medical Resources Corporation$147
  • Biohaven Pharmaceutical Holding Company Ltd.$135
  • plus $1K from 19 others
$378,583in research payments, 2019–2025

Across 81 payments — averaging $4673.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$175K
  • Sumitomo Pharma America, Inc.$139K
  • Genbiopro, Inc.$36K
  • Abbott$28K

What the payments were for

  • Food & beverage$3,33494%
  • Education$2066%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,540 in reported general payments places this provider in the 75th percentile of 308 obstetrics & gynecology providers in Nevada.

See all obstetrics & gynecology providers in Nevada

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol12$670

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in North Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →